Skip to main content
Clinical Trials/NCT02945709
NCT02945709CompletedNot Applicable

Attention Control Treatment for Post Traumatic Stress Disorder

Tel Aviv University1 site in 1 country60 target enrollmentStarted: October 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
60
Locations
1
Primary Endpoint
A diagnosis of PTSD and a total score of severity symptoms, as driven from the CAPS-5 interview

Study Overview

Brief Summary

The purpose of this study is to explore the efficacy of Attention Control Training for Post Traumatic Stress Disorder (PTSD).

ACT was found to be effective in decreasing attention bias variability and PTSD symptoms in combat veterans (Badura-Brack, et al., 2015). It is now important to continue the examination of ACT's efficacy in additional populations of patients with PTSD. Such extension of treatment to other traumatic experiences raises the question of whether the threatening content of the training material could be personalized for each patient.

Detailed Description

The aim of this study is to explore the efficacy of Attention Control Training for Post Traumatic Stress Disorder (PTSD).

ACT was found to be effective in decreasing attention bias variability and PTSD symptoms in combat veterans (Badura-Brack, et al., 2015). It is now important to continue the examination of ACT's efficacy in additional populations of patients with PTSD. Such extension of treatment to other traumatic experiences raises the question of whether the threatening content of the training material could be personalized for each patient.

For this purpose, we will recruit participants that are diagnosed with PTSD and will be randomly assigned to one of three conditions: personalized ACT, non-personalized ACT, or control training We expect that personalized ACT will produce greater reduction in PTSD symptoms relative to a non-personalized ACT, and that both these conditions will be more effective in symptoms reduction than a control condition not designed to affect attention or expose patients to threat stimuli. We also expect the ACT conditions to reduce attention bias variability relative to the control condition.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Meeting a current diagnosis of Post-Traumatic Stress Disorder (PTSD) according to DSM-V (American Psychiatric Association, 2013);

Exclusion Criteria

  • •A diagnosis of psychotic or bipolar disorders.
  • •A diagnosis of a neurological disorder (i.e., epilepsy, brain injury).
  • •Suicidal ideation.
  • •Drugs or alcohol abuse.
  • •Non-fluent Hebrew.
  • •A pharmacological treatment that is not stabilized in the past 3 months (a stable treatment will not be a reason for exclusion from the study).
  • •Pregnancy. -

Arms & Interventions

Personalized ACT

Experimental

The personalized attention control training (ACT), comprised of six computerized sessions, in purpose of modulate biases in attention for personalized threat stimuli.

Intervention: Personalized Attention control training (ACT) (Behavioral)

Non personalized ACT

Active Comparator

The Non-personalized attention control training (ACT), comprised of six sessions, in purpose of modulate biases in attention for non-personalized threat stimuli.

Intervention: Non-personalized Attention control training (ACT) (Behavioral)

Control training

Placebo Comparator

Computerized control training, comprised of six sessions with a variation of the dot-probe task with neutral stimuli

Intervention: Control training. (Behavioral)

Outcomes

Primary Outcomes

A diagnosis of PTSD and a total score of severity symptoms, as driven from the CAPS-5 interview

Time Frame: 40 minutes

The Clinician Administered PTSD Scale (CAPS-5), is a structured interview that will be used to make a diagnosis of PTSD according to the DSM-V criteria. This interview is consists of 30 items regarding the frequency and intensity of PTSD symptoms and a total score of severity is been rated (Weathers, Blake, Schnurr, Kaloupek, Marx, \& Keane, 2013).

Secondary Outcomes

  • Total score of the PTSD Checklist (PCL-5).(10 minutes)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yair Bar-Haim

Professor Yair Bar-Haim

Tel Aviv University

Study Sites (1)

Loading locations...

Similar Trials